H の間の相関関係 胃ヒストポトロジーとNAFLD: 遡及的観察研究
Ioana Alexandra Cardos1, Cătălina Dănilă1, Ovidiu Laurean Pop1
1Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Life (Basel, Switzerland)
|August 28, 2025
まとめ
ヘリコバクター・パイロリ感染症は,非アルコール性脂肪肝 (NAFLD) 線維症のスコア,特にBARDとAPRIのスコアが高くなります. これは,NAFLD患者におけるH. pyloriと肝臓疾患の重度の相関を示唆している.
科学分野:
- ヘパトロジー
- 胃腸内科
- 感染症
背景:
- 以前の研究は,非アルコール性脂肪肝 (NAFLD),肝硬化症,肝硬化症,インスリン抵抗性,非アルコール性脂肪肝炎 (NASH) でヘリコバクター・ピロリ (H. pylori) 感染症の役割を示唆している.
- H. pylori と肝疾患の進行との関連は,特に非侵襲性線維症マーカーに関するさらなる調査を必要としています.
研究 の 目的:
- 非侵襲的なスコアリングシステムを使用して,H. pylori感染とない患者の肝繊維症のリスクを評価する.
- 繊維症の重度スコアと胃部における組織病理学的発見の相関性を評価する.
- 肝繊維症の患者に先発性胃病変のリスクを決定する.
主な方法:
- 110人の患者 (65人のH. pylori陽性,45人のH. pylori陰性) を対象とした研究が行われました.
- 非侵襲性線維症スコア (APRI,BARD,FIB-4) を計算し,マン・ウィットニー検査を用いたグループ間で比較した.
- 多重線形回帰分析を用いて,年齢とH. pyloriの状態との関連を特定した. 組織病理学的検査も行われました.
主要な成果:
- H. pylori陽性のNAFLD患者は,H. pylori陰性患者と比較して,著しく高いBARDスコアとAPRIインデックスを示した.
- FIB-4指数は,H. pylori陽性個体において微小な増加を示した.
- BARDスコアとAPRI指数は,年齢とH. pyloriの状態と有意に関連していました.
結論:
- H. pyloriの感染はNAFLDと胃炎の患者で肝繊維症のスコアが上昇したものと実質的に相関しています.
- この発見は,肝臓疾患におけるH. pylori感染の複雑性と胃組織学的複雑性との関連を示唆しています.
- BARDとAPRIのような非侵襲的なスコアは,H. pyloriを持つNAFLD患者の線維症リスクを評価するのに価値があります.
さらに関連する動画
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
276
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
492
関連する概念動画
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
01:17Gastritis-II: Pathophysiology
542
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
542
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
700
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
700
01:23Gastritis III: Clinical Manifestations and Management
466
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
466
01:30Peptic Ulcer Disease I: Introduction
285
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
285
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546